Dr. Dizman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030
Summary
- I am a Medical Oncology fellow at MD Anderson Cancer Center
Education & Training
Ege Univ- Fac MedClass of 2012
Certifications & Licensure
CT State Medical License 2020 - 2023- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial.Sumanta K Pal, Petros Grivas, Shilpa Gupta, Nazli Dizman, Zeynep Zengin
European Urology. 2025-02-01 - Promises and Challenges of Dietary Intervention in Patients With Prostate Cancer: Lessons Learned From the CAPFISH-3 Trial.Nazli Dizman, Andrea Necchi
Journal of Clinical Oncology. 2024-12-13 - Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice.Nazli Dizman, Ziad Bakouny, Tarek Haykal, Ivy Riano, Aakash Desai
JCO Oncology Practice. 2024-10-07
Press Mentions
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate CancerDecember 30th, 2024- KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024
- Nazli Dizman, MD, and Nicholas Salgia on RCC of Variant HistologyAugust 12th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
